Assignee
TORRENT PHARMACEUTICALS LTD
IN·26 granted patents·13 pending applications·156 citations·filing 1999–2023
Top patents by PatentIndex Score
39 records- 0195US7976871B2Modified release composition of highly soluble drugsTORRENT PHARMACEUTICALS LTD·Filed 2005·Granted Jul 12, 2011·30 cites·4 claims
- 0286US7985422B2Dosage formTORRENT PHARMACEUTICALS LTD·Filed 2003·Granted Jul 26, 2011·18 cites·21 claims
- 0385US8378118B2Pyrazole-based thyroid receptor compoundsTORRENT PHARMACEUTICALS LTD·Filed 2012·Granted Feb 19, 2013·16 cites·15 claims
- 0482US9629818B2Pharmaceutical composition of tapentadol for parenteral administrationTORRENT PHARMACEUTICALS LTD·Filed 2012·Granted Apr 25, 2017·9 cites·16 claims
- 0579US10717727B2Pyridinium compoundsTORRENT PHARMACEUTICALS LTD·Filed 2019·Granted Jul 21, 2020·2 cites·8 claims
- 0679US6248895B1Benzofuroxan compound, method of preparation, pharmaceutical composition and method of treatment using the sameTORRENT PHARMACEUTICALS LTD·Filed 2000·Granted Jun 19, 2001·13 cites·19 claims
- 0778US10233175B2Pyridinium compoundsTORRENT PHARMACEUTICALS LTD·Filed 2016·Granted Mar 19, 2019·2 cites·11 claims
- 0878US7138416B2Compounds and therapeutic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2003·Granted Nov 21, 2006·15 cites·19 claims
- 0976US6608094B2Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2001·Granted Aug 19, 2003·8 cites·41 claims
- 1075US6462057B1Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2000·Granted Oct 8, 2002·9 cites·12 claims
- 1174US9908898B2Fused imidazobenzothiazole compoundsTORRENT PHARMACEUTICALS LTD·Filed 2015·Granted Mar 6, 2018·3 cites·9 claims
- 1273US7939102B2Controlled release formulation of lamotrigineTORRENT PHARMACEUTICALS LTD·Filed 2003·Granted May 10, 2011·3 cites·20 claims
- 1373US7223777B2Compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2002·Granted May 29, 2007·7 cites·15 claims
- 1473US6515132B2Process for the preparation of rosiglitazone maleateTORRENT PHARMACEUTICALS LTD·Filed 2001·Granted Feb 4, 2003·12 cites·10 claims
- 1566US6624178B2Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2002·Granted Sep 23, 2003·3 cites·23 claims
- 1660US2008226711A1Pharmaceutical compositions of duloxetineTORRENT PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 1759US2026062411A1Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its usesTORRENT PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1856US9610247B2Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel diseaseTORRENT PHARMACEUTICALS LTD·Filed 2014·Granted Apr 4, 2017·0 cites·12 claims
- 1956US2008096863A1Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitorTORRENT PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 2054US2011027361A1Extended release dosage form of paliperidoneTORRENT PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 2153US2007167493A1Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 2250US11331334B2Intranasal composition of methylcobalaminTORRENT PHARMACEUTICALS LTD·Filed 2018·Granted May 17, 2022·0 cites·12 claims
- 2350US10471005B2Low dose pharmaceutical compositionTORRENT PHARMACEUTICALS LTD·Filed 2017·Granted Nov 12, 2019·0 cites·13 claims
- 2449US11560357B2Methods of producing pyrazole compoundsTORRENT PHARMACEUTICALS LTD·Filed 2019·Granted Jan 24, 2023·0 cites·8 claims
- 2549US10292948B2Tapentadol nasal compositionTORRENT PHARMACEUTICALS LTD·Filed 2018·Granted May 21, 2019·0 cites·20 claims
- 2649US6111101AProcess for the preparation of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazineTORRENT PHARMACEUTICALS LTD·Filed 1999·Granted Aug 29, 2000·6 cites·11 claims
- 2749US2007105880A1Process for the preparation of alfuzosinTORRENT PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 2847US8822484B2Fused thiazolo and oxazolo pyrimidinonesTORRENT PHARMACEUTICALS LTD·Filed 2013·Granted Sep 2, 2014·0 cites·6 claims
- 2946US2010292251A1Montelukast benzhydryl piperazine salts and process for preparation thereofTORRENT PHARMACEUTICALS LTD·Filed 2009·Application pending·0 cites
- 3044US10227361B2Fused imidazobenzothiazole compoundsTORRENT PHARMACEUTICALS LTD·Filed 2018·Granted Mar 12, 2019·0 cites·13 claims
- 3144US10206923B2Pharmaceutical composition of alogliptin and metforminTORRENT PHARMACEUTICALS LTD·Filed 2016·Granted Feb 19, 2019·0 cites·14 claims
- 3244US2006167113A1Process for preparation of polymorphic form of sertraline hydrochlorideTORRENT PHARMACEUTICALS LTD·Filed 2003·Application pending·0 cites
- 3341US2004106802A1Novel compounds and therapeutic uses thereofTORRENT PHARMACEUTICALS LTD·Filed 2003·Application pending·0 cites
- 3440US10772879B2Pharmaceutical formulationsTORRENT PHARMACEUTICALS LTD·Filed 2016·Granted Sep 15, 2020·0 cites·24 claims
- 3539US2015126530A1Novel Substituted Imidazopyrimidines as Gpbar1 Receptor ModulatorsTORRENT PHARMACEUTICALS LTD·Filed 2012·Application pending·0 cites
- 3637US2002103228A1Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applicationsTORRENT PHARMACEUTICALS LTD·Filed 2001·Application pending·0 cites
- 3736US2019175491A1Topical compositions of apremilastTORRENT PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3834US2019127381A1Substituted fused pyrimidinone compoundsTORRENT PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3928US9963463B2Urea-substituted indanes as P38 map kinase inhibitorsTORRENT PHARMACEUTICALS LTD·Filed 2015·Granted May 8, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when TORRENT PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →